IRAK4 and osteoarthritis: IRAK4 is significantly up-regulated in the synovium of osteoarthritis, and Ad-shIRAK4 decreased its expression via inhibiting the TLR/IL-1R signaling pathway and alleviated synovitis and cartilage degeneration [33].